Social distancing is one of the most recommended policies worldwide to reduce diffusion risk during the COVID-19 pandemic. Based on a risk management perspective, this study explores the mechanism of the risk perception effect on social distancing in order to improve individual physical distancing behavior. The data for this study were collected from 317 Chinese residents in May 2020 using an internet-based survey. A structural equation model (SEM) and hierarchical linear regression (HLR) analyses were conducted to examine all the considered research hypotheses. The results show that risk perception significantly affects perceived understanding and social distancing behaviors in a positive way. Perceived understanding has a significant positive correlation with social distancing behaviors and plays a mediating role in the relationship between risk perception and social distancing behaviors. Furthermore, safety climate positively predicts social distancing behaviors but lessens the positive correlation between risk perception and social distancing. Hence, these findings suggest effective management guidelines for successful implementation of the social distancing policies during the COVID-19 pandemic by emphasizing the critical role of risk perception, perceived understanding, and safety climate.
PurposeTo propose a synthesis method of pseudo-CT (CTCycleGAN) images based on an improved 3D cycle generative adversarial network (CycleGAN) to solve the limitations of cone-beam CT (CBCT), which cannot be directly applied to the correction of radiotherapy plans.MethodsThe improved U-Net with residual connection and attention gates was used as the generator, and the discriminator was a full convolutional neural network (FCN). The imaging quality of pseudo-CT images is improved by adding a 3D gradient loss function. Fivefold cross-validation was performed to validate our model. Each pseudo CT generated is compared against the real CT image (ground truth CT, CTgt) of the same patient based on mean absolute error (MAE) and structural similarity index (SSIM). The dice similarity coefficient (DSC) coefficient was used to evaluate the segmentation results of pseudo CT and real CT. 3D CycleGAN performance was compared to 2D CycleGAN based on normalized mutual information (NMI) and peak signal-to-noise ratio (PSNR) metrics between the pseudo-CT and CTgt images. The dosimetric accuracy of pseudo-CT images was evaluated by gamma analysis.ResultsThe MAE metric values between the CTCycleGAN and the real CT in fivefold cross-validation are 52.03 ± 4.26HU, 50.69 ± 5.25HU, 52.48 ± 4.42HU, 51.27 ± 4.56HU, and 51.65 ± 3.97HU, respectively, and the SSIM values are 0.87 ± 0.02, 0.86 ± 0.03, 0.85 ± 0.02, 0.85 ± 0.03, and 0.87 ± 0.03 respectively. The DSC values of the segmentation of bladder, cervix, rectum, and bone between CTCycleGAN and real CT images are 91.58 ± 0.45, 88.14 ± 1.26, 87.23 ± 2.01, and 92.59 ± 0.33, respectively. Compared with 2D CycleGAN, the 3D CycleGAN based pseudo-CT image is closer to the real image, with NMI values of 0.90 ± 0.01 and PSNR values of 30.70 ± 0.78. The gamma pass rate of the dose distribution between CTCycleGAN and CTgt is 97.0% (2%/2 mm).ConclusionThe pseudo-CT images obtained based on the improved 3D CycleGAN have more accurate electronic density and anatomical structure.
Given that facial features contain a wide range of identification information and cannot be completely represented by a single feature, the fusion of multiple features is particularly significant for achieving a robust face recognition performance, especially when there is a big difference between the test sets and the training sets. This has been proven in both traditional and deep learning approaches. In this work, we proposed a novel method named C2D-CNN (color 2-dimensional principal component analysis (2DPCA)-convolutional neural network). C2D-CNN combines the features learnt from the original pixels with the image representation learnt by CNN, and then makes decision-level fusion, which can significantly improve the performance of face recognition. Furthermore, a new CNN model is proposed: firstly, we introduce a normalization layer in CNN to speed up the network convergence and shorten the training time. Secondly, the layered activation function is introduced to make the activation function adaptive to the normalized data. Finally, probabilistic max-pooling is applied so that the feature information is preserved to the maximum extent while maintaining feature invariance. Experimental results show that compared with the state-of-the-art method, our method shows better performance and solves low recognition accuracy caused by the difference between test and training datasets.
Objective To develop high-quality synthetic CT (sCT) generation method from low-dose cone-beam CT (CBCT) images by using attention-guided generative adversarial networks (AGGAN) and apply these images to dose calculations in radiotherapy. Methods The CBCT/planning CT images of 170 patients undergoing thoracic radiotherapy were used for training and testing. The CBCT images were scanned under a fast protocol with 50% less clinical projection frames compared with standard chest M20 protocol. Training with aligned paired images was performed using conditional adversarial networks (so-called pix2pix), and training with unpaired images was carried out with cycle-consistent adversarial networks (cycleGAN) and AGGAN, through which sCT images were generated. The image quality and Hounsfield unit (HU) value of the sCT images generated by the three neural networks were compared. The treatment plan was designed on CT and copied to sCT images to calculated dose distribution. Results The image quality of sCT images by all the three methods are significantly improved compared with original CBCT images. The AGGAN achieves the best image quality in the testing patients with the smallest mean absolute error (MAE, 43.5 ± 6.69), largest structural similarity (SSIM, 93.7 ± 3.88) and peak signal-to-noise ratio (PSNR, 29.5 ± 2.36). The sCT images generated by all the three methods showed superior dose calculation accuracy with higher gamma passing rates compared with original CBCT image. The AGGAN offered the highest gamma passing rates (91.4 ± 3.26) under the strictest criteria of 1 mm/1% compared with other methods. In the phantom study, the sCT images generated by AGGAN demonstrated the best image quality and the highest dose calculation accuracy. Conclusions High-quality sCT images were generated from low-dose thoracic CBCT images by using the proposed AGGAN through unpaired CBCT and CT images. The dose distribution could be calculated accurately based on sCT images in radiotherapy.
Concurrent engineering has been widely accepted as a viable strategy for companies to reduce time to market and achieve overall cost savings. This article analyzes various risks and challenges in product development under the concurrent engineering environment. A three-dimensional early warning approach for product development risk management is proposed by integrating graphical evaluation and review technique (GERT) and failure modes and effects analysis (FMEA). Simulation models are created to solve our proposed concurrent engineering product development risk management model. Solutions lead to identification of key risk controlling points. This article demonstrates the value of our approach to risk analysis as a means to monitor various risks typical in the manufacturing sector. This article has three main contributions. First, we establish a conceptual framework to classify various risks in concurrent engineering (CE) product development (PD). Second, we propose use of existing quantitative approaches for PD risk analysis purposes: GERT, FMEA, and product database management (PDM). Based on quantitative tools, we create our approach for risk management of CE PD and discuss solutions of the models. Third, we demonstrate the value of applying our approach using data from a typical Chinese motor company.
Background & aims Sarcopenia is associated with poor clinical outcomes of patients who underwent esophagectomy. The current diagnostic criteria for sarcopenia are complex and laborious. We aimed to employ the simple and economic indicator sarcopenia index (SI = creatinine/cystatin C ×100) to screen for sarcopenia and to evaluate its prognostic value in patients with esophageal cancer (EC). Methods Older participants in the National health and nutrition examination survey (NHANES) database (1999–2002) were divided into three groups according to tertiles of the SI value to explore the feasibility of SI in the diagnosis of sarcopenia. Restricted cubic spline (RCS) was utilized to show the non-linear relationship between all-cause mortality and SI. Patients with EC admitted to Jinling Hospital were enrolled to validate the efficacy and prognostic value of SI. Cut-off values of SI were determined using receiver operating characteristic curves. Multivariable logistic analyses and Cox analyses were used to identify the independent factors of postoperative complications and long-term survival, respectively. Results A total of 989 participants were identified from the NHANES database. SI showed the diagnostic value of sarcopenia (tertile 1 vs. tertile 3: odds ratio [OR]=3.67, 95% confidence interval [CI]: 1.52–8.87, p=0.004; tertile 2 vs. tertile 3: OR=1.79, 95% CI: 0.75–4.28, p=0.191) adjusted for race, gender, and body mass index (BMI). Individuals with SI ≤ 68 had a poorer overall survival (OS) (hazard ratio [HR]=2.14, 95% CI: 1.71–2.68, p<0.001), and the RCS plot showed that the all-cause mortality risk gradually decreased with the increase in SI. Then, 203 patients with EC were enrolled, of which 76 patients were diagnosed with sarcopenia. There was a linear correlation between SI and skeletal muscle index and prealbumin, indicating that SI was reliable for diagnosing sarcopenia. Patients in the high sarcopenia risk group (Male: SI < 62; Female: SI < 55) showed a higher incidence of complications (OR=3.50, 95% CI: 1.85–6.61, p<0.001) and poorer long-term survival (HR=2.62, 95% CI: 1.02–6.77, p=0.046). Conclusion SI could be used to identify sarcopenia in patients with EC, and it is a useful prognostic factor of postoperative complications and long-term survival.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.